Precision Peptide Company (CSE:BPC | OTCQB:PNGAF)
Public Peptide Wellness Platform
Precision Peptide Company
Peptides, Reimagined.
Pure peptide formulations with advanced delivery systems, engineered for the future of human health and scalable consumer wellness.
CSE: BPCOTCQB: PNGAF
Investor OverviewCorporate Site
Paid advertisement. Not investment advice. Review issuer filings before investing. Product and platform language is for general awareness only and does not constitute medical advice.
Investor Snapshot
Two-market visibility with one clean investor story.
The Precision Peptide Company is positioned around peptide-based wellness products, advanced delivery formats, and North American market expansion.
Live Market Quote
Track BPC and PNGAF in real time.
Live TradingView quote panel for the Canadian and U.S. traded listings.
Precision Peptide Market Watch
Strategic Advisor Spotlight
Dave Asprey brings wellness-category credibility to the platform.
Dave Asprey, a widely known biohacking and human-performance voice, was announced as a Strategic Business Advisor to Amino Innovations, a Precision Peptide Company subsidiary. His involvement gives the story a direct connection to the longevity, recovery, and wellness audiences already watching the peptide category.
Dave Asprey
Health entrepreneur, author, and public wellness figure connected to the company’s peptide innovation strategy through Amino Innovations. Verify advisor information against issuer materials.
Operating Thesis
Built at the intersection of formulation, delivery, and consumer wellness.
Needle-free direction
Patch-based and oral formats are central to the company’s next-wave delivery strategy.
Peptide wellness portfolio
Product development spans recovery, cognitive, longevity, anti-inflammatory, and dermal categories.
North American growth
The company is focused on distribution scale as demand for advanced wellness formats evolves.
Product Portfolio
Amino Innovations product lines support the broader platform narrative.
Portfolio names are presented for company awareness. Product availability, labeling, and permitted claims vary by jurisdiction.
BPC
Recovery category
Chill
Cognitive category
Ageless
Longevity category
KPV
Anti-inflammatory category
GHK-Cu
Dermal category
Risk & Disclosure
Read the filings before trading.
This is sponsored investor-awareness content and is not a recommendation to buy or sell securities. Small-cap and OTC securities can be highly volatile, illiquid, and sensitive to promotion, financing, dilution, regulatory developments, and market sentiment.
Product and platform descriptions are not medical advice and are not intended to diagnose, treat, cure, or prevent any disease.
Disclosure: The Publisher is engaged in the business of marketing and advertising the securities of publicly traded companies in exchange for compensation.
Compensation and campaign term: Precision Peptide has contracted the Publisher for a one-month advertising and promotional campaign. The total compensation paid or payable for this campaign is $65,000 USD, payable to OCI Inc., a subsidiary of Thunderdome Holdings LLC, the owner and operator of AllStocksNews.com.
Share with your friends!
Informational only; not investment advice. Verify details through official SEC filings and primary-source disclosures. No guarantee of outcomes.
Follow the public company building around peptide delivery.
CSE: BPC | OTCQB: PNGAF. Review company materials, press releases, and public filings before making any investment decision.